A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression
Clinical trial NCT01536743 · COMPLETED
Trial details
- NCT number
- NCT01536743
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-15
- Primary completion
- 2020-02-24
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.